MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

Начало・Списък с акции・Lisata Therapeutics

L
Lisata Therapeutics

Отворен

2.66 0.38

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

2.36

Максимум

2.98

Ключови измерители
By Trading Economics
Служители	26

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+453.51% upside

Дивиденти
By Dow Jones
Следващи печалби	11.08.2025 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-2.1M 17M
Предишно отваряне	2.28
Предишно затваряне	2.66

Lisata Therapeutics Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

14.07.2025 г., 22:07 ч. UTC

Значими двигатели на пазара

Trade Desk Rises on S&P 500 Inclusion

14.07.2025 г., 17:06 ч. UTC

Значими двигатели на пазара

Crypto Assets Rally Ahead of Possible U.S. Legislation

14.07.2025 г., 16:47 ч. UTC

Придобивния, сливания и поглъщания

NatWest to Sell Stake in Permanent TSB

14.07.2025 г., 23:46 ч. UTC

Пазарно говорене

Nikkei May Rise as Yen Weakens -- Market Talk

14.07.2025 г., 23:38 ч. UTC

Пазарно говорене

Gold Edges Higher Ahead of U.S. CPI Data -- Market Talk

14.07.2025 г., 23:37 ч. UTC

Пазарно говорене

ANZ's Institutional Earnings Likely to Weigh on Outlook -- Market Talk

14.07.2025 г., 23:29 ч. UTC

Пазарно говорене

South32 Bull Eyes Possible Last-Minute Power Deal for Mozal -- Market Talk

14.07.2025 г., 23:29 ч. UTC

Пазарно говорене

Global Energy Roundup: Market Talk

14.07.2025 г., 23:02 ч. UTC

Печалби

China Vanke: Additional Provision for Asset Impairment Also Among Factors Weighing on Results >000002.SZ

14.07.2025 г., 23:02 ч. UTC

Печалби

China Vanke: Weakness in Overall China Real-Estate Sector Weighed on Results >000002.SZ

14.07.2025 г., 23:02 ч. UTC

Печалби

China Vanke 1H Loss Was CNY9.85B >000002.SZ

14.07.2025 г., 23:01 ч. UTC

Печалби

China Vanke Sees 1H Loss CNY10.0B-Loss CNY12.0B >000002.SZ

14.07.2025 г., 23:01 ч. UTC

Печалби

China Vanke Expects 1H Loss to Widen >000002.SZ

14.07.2025 г., 20:50 ч. UTC

Пазарно говорене

Tech, Media & Telecom Roundup: Market Talk

14.07.2025 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

14.07.2025 г., 20:07 ч. UTC

Пазарно говорене

Cloud Computing Giants Will Be the Winner from Software's Loss -- Market Talk

14.07.2025 г., 20:05 ч. UTC

Пазарно говорене

Adobe and Salesforce May Struggle to Keep Up With AI Agents -- Market Talk

14.07.2025 г., 19:11 ч. UTC

Пазарно говорене

Oil Retreats Despite Trump Threats of Russia Sanctions -- Market Talk

14.07.2025 г., 19:09 ч. UTC

Пазарно говорене

Gold Breaks a 3-Day Win Streak -- Market Talk

14.07.2025 г., 18:59 ч. UTC

Пазарно говорене

Hotter Weather Outlook, LNG Flows Boost U.S. Natural Gas -- Market Talk

14.07.2025 г., 18:30 ч. UTC

Придобивния, сливания и поглъщания

Synopsys Buy of Ansys Gets China OK. The $35 Billion Deal Is Set to Close. -- Barrons.com

14.07.2025 г., 18:25 ч. UTC

Пазарно говорене

Dollar Gains, Treasury Yields Lose Steam as Trump Threatens Russia -- Market Talk

14.07.2025 г., 18:25 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

14.07.2025 г., 16:59 ч. UTC

Пазарно говорене

Goldman Sachs Lifts 2H25 Crude Price Views -- Market Talk

14.07.2025 г., 16:53 ч. UTC

Горещи акции

Stocks to Watch Monday: Kenvue, Tesla, Synopsys, Robinhood -- WSJ

14.07.2025 г., 16:27 ч. UTC

Пазарно говорене

Oil Falls as Investors Monitor U.S.-EU Trade, Trump's Russia Sanction Threats -- Market Talk

14.07.2025 г., 16:20 ч. UTC

Пазарно говорене

Печалби

Auto & Transport Roundup: Market Talk

14.07.2025 г., 16:20 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

14.07.2025 г., 16:15 ч. UTC

Пазарно говорене

Global Commodities Roundup: Market Talk

14.07.2025 г., 16:12 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Waters Closer to Thermo Fisher, Danaher With Becton Dickinson Unit -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Lisata Therapeutics Прогноза

Ценова цел

By TipRanks

453.51% нагоре

12-месечна прогноза

Среден 15 USD 453.51%

Висок 15 USD

Нисък 15 USD

Според 1 анализатори от Wall Street, предложили 12-месечна ценова цел за Lisata Therapeutics през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

1 ratings

Купи

Задържане

Продай

Според 1 анализатори, дали борсови рейтинги на Lisata Therapeutics през последните 3 месеца.

Финанси

Относно Lisata Therapeutics

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.